Compact system could shorten diagnostic time from days to hours, bring testing to point of care
A team of Massachusetts General Hospital (MGH) investigators has developed a device with the potential of shortening the time required to rapidly diagnose pathogens responsible for health-care-associated infections from a couple of days to a matter of hours. The system described in the journal Science Advances also would allow point-of-care diagnosis, as it does not require the facilities and expertise available only in hospital laboratories.
“Health-care-associated infections are a major problem that affects more than 600,000 patients each year, more than 10 percent of whom will die, and incurs more $100 billion in related costs,” says Ralph Weissleder, MD, PhD, director of the MGH Center for Systems Biology, Thrall Family Professor of Radiology at Harvard Medical School (HMS) and co-senior author of the report. “Rapid and efficient diagnosis of the pathogen is a critical first step in choosing the appropriate antibiotic regimen, and this system could provide that information in a physician’s office in less than two hours.”
While considered the gold standard for diagnosing bacterial infections, traditional culture-based diagnosis can take several days and requires specialized equipment, trained laboratory personnel and procedures that vary depending on the particular pathogen. Emerging genetic approaches that identify bacterial species by their nucleic acid sequences are powerful but still require complex equipment and workflows, restricting such testing to specialized hospital laboratories.
The system developed by the MGH team, dubbed PAD for Polarization Anisotropy Diagnostics, allows for accurate genetic testing in a simple device. Bacterial RNA is extracted from a sample in a small, disposable plastic cartridge. Following polymerase chain reaction amplification of the RNA, the material is loaded into a 2-cm plastic cube containing optical components that detect target RNAs based on the response to a light signal of sequence-specific detection probes. These optical cubes are placed on an electronic base station that transmits data to a smartphone or computer where the results can be displayed.
In this proof-of-principle study, the team used a prototype PAD system containing four optical cubes to test clinical samples from nine patients and compared the results with those acquired by conventional microbiology cultures. Testing for the presence of five important bacterial species — E. coli, Klebsiella, Acinetobacter, Pseudomonas, and Staph aureus — and for factors indicating the virulence and antibiotic resistance of specific strains produced identical results with both procedures. But while PAD provided results in less than two hours, the bacterial culture process took three to five days.
The team has now designed probes for more than 35 bacterial species and virulence factors, and the overall cost of running the PAD assay should not exceed $2.00.
“This prototype still needs several improvements, including building a self-contained system housing all functions, further reducing the current assay time to less than one hour and expanding the panel of probes to even more pathogens and resistance factors,” says Hakho Lee, PhD, of MGH Center for Systems Biology (CSB), co-senior author of the report and an associate professor of Radiology at HMS.
“But we can see three immediate applications for a system that can provide such rapid and accurate results – quickly diagnosing a patient’s infection, determining whether antibiotic-resistant bacteria are present in a group of patients, and detecting bacterial contamination of medical devices or patient environments.”
The Latest on: Bacterial infections
via Google News
The Latest on: Bacterial infections
- Eye Infections Treatment Market - Current Impact to Make Big Changeson May 12, 2020 at 8:19 am
AMA Research added a comprehensive research document of 200+ pages on 'Eye Infections Treatment' market with detailed insights on growth factors and strategies. The study segments key regions that ...
- Clarametyx Biosciences Launches With an Ambitious Strategy to Address Life-threatening Bacterial Infectionson May 12, 2020 at 6:14 am
Clarametyx Biosciences launches with a technology platform targeting bacterial resistance mechanisms to fight life-threatening infections.
- FMI Analyzes Impact of COVID-19 on Varicella Zoster Infection Treatment Market; Stakeholders to Focus on Long-term Dimensionson May 11, 2020 at 10:35 pm
Future Market Insights (FMI) has published a new report on the varicella zoster infection treatment market titled "Varicella Zoster Infection Treatment Market: Global Industry Analysis 2012 - 2016 and ...
- Study: Diarrhea-causing bacteria provoke host's response to increase infectivityon May 11, 2020 at 10:25 pm
A type of E. coli bacteria that causes bloody diarrhea uses an amino acid produced by the body in response to infection to intensify its symptoms, according to a new study from UT Southwestern ...
- Day Zero Diagnostics Awarded $6.2 Million in CARB-X Funding for Development of New Technology to Rapidly Diagnose Superbug Infections and Determine the Most Effective ...on May 11, 2020 at 1:31 pm
Day Zero Diagnostics, Inc., an infectious disease diagnostics company using genome sequencing and machine learning to combat the rise of antibiotic-re ...
- Research reinforces the idea of embracing nonantibiotic approaches to treat bacterial infectionson May 9, 2020 at 7:32 pm
As interest in the application of plasma medicine -- the use of low-temperature plasma created by an electrical discharge to address medical problems -- continues to grow, so does the need for ...
- New Cumberland Mayor Doug Morrow hospitalized with lung infectionon May 8, 2020 at 5:29 pm
New Cumberland Mayor Doug Morrow is hospitalized in the Intensive Care Unit at Geisinger Holy Spirit Hospital in Camp Hill. Sources close to the family said that Morrow, 53, was admitted to the ...
- A biomimetic peptide recognizes and traps bacteria in vivo as human defensin-6on May 8, 2020 at 11:49 am
Using broad-spectrum antibiotics for microbial infection may cause flora disequilibrium, drug-resistance, etc., seriously threatening human health. Here, we design a human defensin-6 mimic peptide ...
- Why are there so many drugs to kill bacteria, but so few to tackle viruses?on May 8, 2020 at 7:12 am
As the end of the second world war neared, mass production of the newly developed antibiotic penicillin enabled life-saving treatment of bacterial infections in wounded soldiers. Since then, ...
- Antibiotics treat infections by either killing or sterilizing bacteriaon May 2, 2020 at 8:55 am
Antibiotics work by rupturing the protective cell walls of harmful bacteria. They start working immediately but you may not feel relief for 1-3 days.
via Bing News